1 asset in Peroxisome Biogenesis Disorder Type 3B

Therapeutic assets addressing Peroxisome Biogenesis Disorder Type 3B, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cald Hr-D Peroxisome Biogenesis Disorder Type 3B	Masonic Cancer Center, University of Minnesota	P2	CCC (53)